Join Sai Baba Announcement List


DOWNLOAD SAMARPAN - Nov 2018





Author Topic: Tulsi Can Help Keep Swine Flu Away  (Read 15989 times)

0 Members and 1 Guest are viewing this topic.

Offline rOhit beHaL

  • Member
  • Posts: 1425
  • Blessings 32
  • SAIRAM
Swine flu Vaccine seems Safe
« Reply #15 on: September 10, 2009, 07:35:51 AM »
  • Publish
  • Swine Flu Vaccine Seems Safe: Experts

         More information about the H1N1 swine flu at the U.S. Centers for Disease Control and Prevention. - http://www.cdc.gov/H1N1FLU/

    FRIDAY, Sept. 4 (HealthDay News) -- Despite persistent public concern that H1N1 vaccines being tested might have unforeseen side effects, experts reiterated Thursday that so far, at least, the shots seem safe.

    "There have been no red flags at all," Dr. Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, told HealthDay.
    A trial designed to test the vaccine on healthy adults began on Aug. 7, while another trial involving children started Aug. 18.
    "We wanted to wait about a week after the first trial to see if there were any glaring safety issues. There were not, so one-and-a-half weeks later, we started the trial in children," Fauci said.

    And Fauci is optimistic that the vaccine will continue to be safe. "It's unlikely there will be safety issues," he said. "We don't expect any because this vaccine is strikingly similar to the seasonal vaccine we give every year to millions and millions and millions of people."

    Still, rare side effects will only come to light after millions of people have been vaccinated and after different population subgroups have been exposed to the vaccine. "No clinical trial in the world is going to be large enough to be able to detect an event that occurs one in every 100,000 people," Fauci said. "The only way to pick that up is after the fact, when a lot of people get vaccinated and good surveillance picks it up."

    Another expert agreed. "One of the challenges is that sometimes on the safety issue, only large-scale use will uncover rare events," said Dr. Melinda Moore, senior health researcher with the RAND Corporation in Arlington, Va., and a former epidemiologist with the U.S. Centers for Disease Control and Prevention. "That's not unique to this product. That's why there's so much after-market surveillance."

    Such a surveillance system will be in place and operable when the first vaccinations start to roll out. Fauci anticipates that 45 million to 50 million doses will be available by Oct. 15. Many people are painfully aware of a U.S. government decision in 1976 to vaccinate 43 million people against swine flu -- it backfired badly.

    Not only did the dreaded outbreak never materialize, but some 500 Americans who did get vaccinated came down with a rare neurodegenerative condition called Guillain-Barre syndrome, which many experts believe was linked to the shot. Twenty-five of those 500 people died.

    One thing that's already different about this year's H1N1 virus: The 1976 virus never spread beyond 240 soldiers stationed at Fort Dix, N.J., while the current outbreak has already sickened more than 200,000 people worldwide, killing 2,200 or more, according to the World Health Organization.
    "That [1976] virus never evolved," Moore said. "People thought it was going to be a new pandemic. It didn't turn out to be. The threat wasn't as big as they thought. This virus has already demonstrated that it has spread."

    Still, segments of the public may be wary of any vaccine they perceive as being rushed out too fast. A report in a recent issue of the BMJ found that more than half of all health-care workers surveyed in Hong Kong have already decided not to get vaccinated because of fears about safety and doubts on efficacy. U.S. officials do not yet know whether the vaccine will require one or two doses. "We will know in a week or so if one dose is going to be enough," Fauci said. "We're hoping it's going to be one."

    Reports published Thursday by drug maker Novartis suggest its vaccine may be effective after just one jab.

    If two doses are needed, researchers will need to figure out how far apart they should be given, Moore said, and whether an adjuvant -- something to boost the immune response -- is called for.

    "They will have to balance it all out," she said. "Ultimately the product needs to be licensed. This is not a theoretical exercise. The virus is here and so is the U.S. population -- and so is the flu season."


    Source - http://www.ajc.com/health/content/shared-auto/healthnews/flu-/630705.html

    Sairam,
    rOhit beHaL
    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

    Offline rOhit beHaL

    • Member
    • Posts: 1425
    • Blessings 32
    • SAIRAM
    Video - Swine Flu Vaccine
    « Reply #16 on: September 11, 2009, 04:11:52 AM »
  • Publish
  • Associated Press

    Video - Swine Flu Vaccine
    Good news in the World's Swine flu fight:
    One dose of the New Swine Flu Vaccine looks strong enough to protect Adults and can spark Protection within 10 days of the Shot.
    (Sept. 11)


    [youtube=425,350]http://www.youtube.com/watch?v=QkiY_Om4xRI[/youtube]

    Source - http://www.youtube.com/user/AssociatedPress

    Sairam,
    rOhit beHaL
    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

    Offline rOhit beHaL

    • Member
    • Posts: 1425
    • Blessings 32
    • SAIRAM
    H1N1 Vaccine Works
    « Reply #17 on: September 11, 2009, 02:05:04 PM »
  • Publish
  • US Trials confirm one Dose of H1N1 Vaccine Works
    Trials also showed very few side-effects and all so far were minor
    Reuters

    Washington: US trials of Sanofi- Pasteur SA’s and CSL Ltd’s H1N1 swine flu vaccines confirm only one dose is needed to protect people, US health officials said on Friday.

    “I am very pleased today to be able to tell you that the initial results from the NIH (National Institutes of Health) sponsored trial corroborate and reinforce the findings from the companies,” Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, told a news conference.

    Fauci said the immune response was quick, too—people appear to be protected eight to 10 days after being vaccinated.

    “Americans who get their H1N1 vaccine will most likely be immunized and protected against the virus sooner than we thought,” Health and Human Services secretary Kathleen Sebelius told the news conference.

    Fauci said the trials also showed very few side-effects and all so far were minor. CSL reported on Thursday that other trials showed just a single dose of vaccine was needed and, last week, Novartis AG and China’s Sinovac Biotech Ltd also said they could protect people with one dose of their vaccines.

    Anne Schuchat of the US Centers for Disease Control and Prevention said H1N1 flu was now active in all 50 US states.

    Source - http://www.in.com/news/readnews-current-affairs-us-trials-confirm-one-dose-of-h1n1-vaccine-works-10770607-936a06d7d0aa2a41e1204db0095f1c797a8d76a4-1.html?utm_source=redirect&utm_medium=in.com

    Sairam,
    rOhit beHaL
    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

    Offline rOhit beHaL

    • Member
    • Posts: 1425
    • Blessings 32
    • SAIRAM
    Re: Tulsi Can Help Keep Swine Flu Away
    « Reply #18 on: September 14, 2009, 12:58:39 PM »
  • Publish

  • Retail sale of Flu Drugs from Today
    15 Sep 2009, 0004 hrs IST,
    Sushmi Dey, ET Bureau

    NEW DELHI: The government will allow retail sale of anti-viral drug ‘oseltamivir’, prescribed for the treatment of swine flu from Tuesday, said a health ministry official.

    The medicine, which was available only through government hospitals, will now be available in specified chemist shops, he said, requesting anonymity.

    The medicine will be sold only after verifying prescriptions. There are around 480 designated chemists across the country, who can sell the drug. The government will also allow designated private hospitals for the treatment of swine flu to procure the drug from pharmaceutical companies on their own.

    Domestic drug firms such as Cipla, Ranbaxy, Strides Arcolab and Hetero have developed generic version of oseltamivir.

    Once restricted sale is allowed, patients will have to carry two copies of prescription of the drug from doctor to chemist. However, the retail prices are likely to be higher than the government procurement price, said an industry official. The government procures the drug at around Rs 280 for 10 tablets from these companies.

    Initially, the government did not allow retail sale, as it was worried that it may promote drug resistance. But, with increasing number of positive cases and concerned about the supply and availability of the drug across the country, the health ministry decided to allow restricted retail sale of the drug.

    “It will be difficult for the government to provide the drug to private sector once it designates private hospitals for treatment. The restricted sale will allow such hospitals to procure for themselves,” said the official.

    According to the health ministry estimates, so far 29,530 people have been tested for swine flu in various government and private laboratories across the country. Out of this, 6,359 people have been found positive. India has reported 189 deaths due to swine flu till Monday evening, of which six people died on Monday itself.

    Source - http://economictimes.indiatimes.com/news/news-by-industry/healthcare-/-biotech/healthcare/Retail-sale-of-flu-drugs-from-today/articleshow/5011531.cms

    Sairam,
    rOhit beHaL


    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

    Offline rOhit beHaL

    • Member
    • Posts: 1425
    • Blessings 32
    • SAIRAM
    India to import 15 lakh Swine Flu Vaccine Shots
    « Reply #19 on: September 16, 2009, 09:25:31 PM »
  • Publish
  • India to import 15 lakh Swine Flu Vaccine Shots
     Thursday, September 17, 2009 2:33 IST
    Vineeta Pandey / DNA
     
    New Delhi - India is planning to procure 15 lakh doses of swine flu vaccine from GlaxoSmithKline (GSK) and Novartis. The vaccine will be available by January and will be used mainly for doctors, paramedics and rapid response teams directly involved with patients, and scientists handling patients’ samples for H1N1 testing.

    In the US on Tuesday, the Food and Drug Administration approved the swine flu vaccine — a long-anticipated step  — ordering 195 million doses for now.(the vaccination programme will start next month).

    And China licensed an institute in Shanghai to begin producing a single-dose vaccine, raising the number of such manufacturers in the country to three (the institute will produce three million doses by October and 10 million by the yearend; China has approved free vaccination for people, who need to be above three years).

    In India, the health ministry has said the vaccine will be allowed to be administered on citizens only after clinical trials
    (the side effects of influenza vaccines include paralysis, according to Dr VM Katoch, director, Indian Council for Medical Research).

     Serum Institute begins animal trials of H1N1 vaccine, While the government has agreed to conduct bridge studies with GSK on the efficacy of the vaccine on the Indian population, a formal deal with Novartis is yet to be signed.

    Recently, GSK invited India to participate in the second and third stages of trials on humans. Although India wanted a trial size of 6,000-7,000 people, it agreed for a bridge study on 400-600 people to fast-track the process.

    Health ministry officials also said that Indian pharmaceutical firms are at an advanced stage of preparing the vaccine. “International vaccines will be available in the global market by January, while our vaccine will be ready by March,” said Dr Katoch. He said the Indian firms will also supply the vaccine - to be cheaper compared to the American one — to the World Health Organisation for other countries.

    The government’s priority for immunisation, apart from medical and scientific staff, will be high-risk populations like pregnant women, people living with or caring for babies, and adults with chronic immune problems.

    Source - http://www.dnaindia.com/india/report_country-to-import-15-lakh-swine-flu-vaccine-shots_1290879

    Sairam,
    rOhit beHaL
    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

    Offline rOhit beHaL

    • Member
    • Posts: 1425
    • Blessings 32
    • SAIRAM
    Anti swine flu drug 'FLUVIR' now available in India
    « Reply #20 on: September 22, 2009, 10:17:48 AM »
  • Publish
  • Anti swine flu drug 'FLUVIR' now available in India
    PTI - Tuesday, September 22, 2009
     
    Mumbai - Hetero Healthcare Limited, an Indian drug manufacturer, today announced that the company's anti swine flu drug 'FLUVIR' is now available in retail markets across India.
         
    Hetero is the only Indian pharma company to have the licensing rights from Hoffmann-La Roche Ltd to manufacture and supply Oseltamivir (generic name of anti H1N1flu drug) in India as well as in other 100 underdeveloped and developing countries.

    Hetero brings to India FLUVIR (similar to Tamiflu) with collaboration benefits of expertise and back-up yielding product of international quality, a company release said here today.
       
    FLUVIR is the first Oseltamivir drug launched in Indian retail market.
         
    Before the Government notification of allowing retail sale of anti-viral drug Oseltamivir, the Centre procured 19 million FLUVIR capsules from Hetero to check the recent outbreak of deadly H1N1 flu in India, Srinivas Reddy, marketing director, Hetero said.

    FLUVIR, which was available only through Government hospitals, will now be available in around 480 designated medical shops having Schedule X licence across the country, he said.

    Reddy said responding to Centre's request to increase the production capacity from 100 million capsules per month to 200 million capsules per month, Hetero has come up with dedicated manufacturing facilities in Vishakapatnam exclusively to produce FLUVIR.

    It is fully prepared with adequate raw materials and manufacturing capacities to meet the demand of FLUVIR to treat millions of swine flu patients, he said.

    Persons who want to purchase the drug have to produce two copies of prescription of the drug, the company release said.

    While selling this drug, pharmacists have to make a record of the prescriptions, name of the doctor and the person to whom it was sold. The price of the drug is Rs 450 for 10 capsules -- for a single therapy.
         
    "With our manufacturing facilities exclusively for FLUVIR, Hetero will be able to deliver sufficient number of doses to treat more than 2 crore people in an emergency situation," Reddy said.

    Source - http://www.dnaindia.com/mumbai/report_anti-swine-flu-drug-fluvir-now-available-in-india_1292250

    Sairam,
    rOhit beHaL


    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

    Offline rOhit beHaL

    • Member
    • Posts: 1425
    • Blessings 32
    • SAIRAM
    Swine Flu Generic Drugs available, No Takers
    « Reply #21 on: September 27, 2009, 07:54:55 AM »
  • Publish
  • Swine Flu Generic Drugs "Fluvir and Natflu" available, No Takers
    Deepa Suryanarayan / DNA
     Sunday, September 27, 2009

    Mumbai - While the two new effective drugs to counter H1N1 virus — Fluvir and Natflu — or Oseltamivir (generic name for tamiflu) have been made available at chemist shops in Mumbai in the past four days, there are hardly any sales or even enquiries for the drug coming in, said chemists.

    Only chemists with a ‘Schedule X’ licence can sell the drug. To ensure that the drug is readily available to the public, the state government has also issued as many as 91 fresh licenses last week, bringing to 143 the number of designated medical shops with the license to sell the drug.

    However, while the supply is available, the demand seems to have fizzled out in the city. “I received the stock four days ago, but am yet to sell a single tablet of the 200 tablets that I have,” said Ranjeet Ranawat, proprietor, Red Rose Chemists, Marine Lines, which has the Schedule X license, allowing it to stock and sell Fluvir.

    “Swine flu cases are on the wane. So the demand has gone down,” he said, adding, that he informed nearby private hospitals, including Bombay Hospital about the availability of the drug. While 282 patients were screened in government hospitals on Saturday, no one tested positive. No deaths were reported either, said officials.

    “Not many are aware of its availability, as it is being sold under a new name. Besides, the drug is available free at government hospitals, why would they shell out money for it?” asked another chemist in Dadar, adding that he too had not seen a single prescription for the drug.

    One common misconception, chemists said, was that the drug which is now available is not called Tamiflu — which is the brand name of Hoffmann-La Roche Ltd for Oseltamivir drug. Hetero Healthcare Limited has launched the drug as ‘Fluvir’ in the retail market, while Natco, a pharmaceutical company launched the drug as ‘Natflu.’

     The drug is available in 143 medical shops in the state, having Schedule X license, out of which at least 10 are in Mumbai. Two copies of prescription have to be produced to purchase the drug. While selling this drug, pharmacists have to make a record of the prescription, name of the doctor and the person to whom it was sold.

    The drugs are priced in the range of Rs 450 - Rs 480 for 10 capsules.

    Source - http://www.dnaindia.com/mumbai/report_swine-flu-drugs-available-no-takers_1293276

    Sairam,
    rohit beHaL


    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

    Offline rOhit beHaL

    • Member
    • Posts: 1425
    • Blessings 32
    • SAIRAM
    Now, SMS Swine Flu for Help
    « Reply #22 on: October 06, 2009, 12:26:26 AM »
  • Publish
  • Now, SMS Swine Flu for Help
     Rishi Banerji / DNA
    Tuesday, October 6, 2009

     
     Surat: To help citizens battle the H1N1 virus and create more awareness, Surat's civic body has come up with a unique SMS and email service. Surat Municipal Corporation (SMC) after launching the service on Monday urged doctors to pool in with information on swine flu.
    Citizens would now be able to call for help by just sending an SMS on +91 9724344989.
    Doctors and general public can send information on h1n1smc@gmail.com which will keep the SMC updated.

    "At present, swine flu treatment is provided at many hospitals. Some hospitals inform us and give us details but we are not able to get complete information. If we are informed about cases on time, effective treatment can be provided to the patients," said Hemant Desai, in-charge deputy municipal commissioner (health & hospitals) of SMC.

    Desai added that doctors will need to provide correct information and update the civic body regularly. Also, strict action will be taken against the doctors and hospitals which fail to update the civic body.

    A special guideline to tackle suspected and positive swine flu patients was issued to clinics and hospitals in the city on Monday. The guideline stated that Oseltamivir tablets should be given to patients suffering from category B type of swine flu, while antiviral treatment should be provided to all C type patients - even if hospital has not entered with an MoU with the state government. In absence of a ventilator, hospitals have been asked to shift patients infected with the virus to other hospitals.

    Source - http://www.dnaindia.com/india/report_now-sms-swine-flu-for-help_1295486



    Sairam,
    rOhit beHaL

    " IF YOU SOW FAITH, YOU WILL REAP MIRACLES "

     


    Facebook Comments